Crimson Publishers Publish With Us Reprints e-Books Video articles

Abstract

Interventions in Obesity & Diabetes

Fatty Acid Profiles and Desaturase Indices as Biomarkers of Metabolic Dysfunction in Obesity

Submission: October 08, 2026;Published: October 29, 2026

DOI: 10.31031/IOD.2026.07.000658

ISSN : 2578-0263
Volume7 Issue2

Abstract

Obesity is a multifactorial metabolic disorder characterized by excessive adipose tissue and profound disturbances in lipid metabolism. This review provides a comprehensive overview of current evidence on Fatty Acid (FA) profiles and estimated desaturase activities in individuals with obesity, with emphasis on Stearoyl-CoA Desaturase-1 (SCD1), Delta-5 Desaturase (D5D), and Delta-6 Desaturase (D6D) as potential biomarkers of metabolic dysfunction integrating evidence from human observational studies, experimental models, and genetic investigations. A comprehensive evaluation of FA composition, desaturase enzyme pathways, and their associations with metabolic complications in obesity. We examined biochemical regulation, methodological considerations, genetic influences (including FADS polymorphisms), and the impact of nutritional and pharmacological interventions. Qualitative alterations in FA composition and desaturase activity are increasingly recognized as important determinants of obesity-associated metabolic dysfunction. individuals with obesity frequently exhibit altered FA profiles and estimated desaturase activities. Evidence from human, experimental, and genetic studies supports mechanistic links between desaturase dysregulation, lipotoxicity, inflammation, and cardiometabolic risk. However, methodological heterogeneity, the indirect nature of estimated desaturase indices, population-specific genetic and dietary effects, and limited prospective validation represent important challenges. Altered FA profiles and desaturase indices are promising biomarkers for characterizing metabolic dysfunction in obesity. Future integration of lipidomic approaches with genomic, metabolic, and clinical parameters may improve identification of individuals at increased cardiometabolic risk and support personalized nutritional and therapeutic strategies. Prospective longitudinal and intervention studies remain essential to establish incremental predictive value, reproducibility, and clinical applicability before translation into routine practice.

Keywords:Obesity; Fatty acid; Biochemical pathways; Clinical associations; Methodological considerations; Therapeutic strategies

Get access to the full text of this article

About Crimson

We at Crimson Publishing are a group of people with a combined passion for science and research, who wants to bring to the world a unified platform where all scientific know-how is available read more...

Leave a comment

Contact Info

  • Crimson Publishers, LLC
  • 260 Madison Ave, 8th Floor
  •     New York, NY 10016, USA
  • +1 (929) 600-8049
  • +1 (929) 447-1137
  • info@crimsonpublishers.com
  • www.crimsonpublishers.com